ALMATICA PHARMA INC
FDA Approved Drugs

ALMATICA PHARMA INC

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 7
  • Latest Approval Date May 09, 2023
  • Data Source FDA
  • First Approval Date Jan 28, 2011
Company Overview

Company

ALMATICA PHARMA INC

Country

U.S.A

Social Profiles

Company Snapshot

ALMATICA PHARMA INC

10 Bloomfield Avenue Building B, Suite 2 Pinebrook, NJ 07058

U.S.A

www.almatica.com/ customerservice@almatica.com View on Map
FDA Approved Drug Records ( 7 records )
2022
31 Jan
RX Application: 215428

Drug Name

CITALOPRAM HYDROBROMIDE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2022-01-31

215428 / 1

Active Ingredient

CITALOPRAM HYDROBROMIDE

Application Number

215428

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2022-01-31

Regulatory Status

RX

2011
28 Jan
RX Application: 22544

Drug Name

GRALISE

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2011-01-28

22544 / 1

Active Ingredient

GABAPENTIN

Application Number

22544

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2011-01-28

Regulatory Status

RX

2011
28 Jan
RX Application: 22544

Drug Name

GRALISE

Product Number

2

Dosage Form

-

Strength

600MG

Approval Date

2011-01-28

22544 / 2

Active Ingredient

GABAPENTIN

Application Number

22544

Product Number

2

Dosage Form

-

Strength

600MG

Approval Date

2011-01-28

Regulatory Status

RX

2023
18 Apr
RX Application: 22544

Drug Name

GRALISE

Product Number

3

Dosage Form

-

Strength

450MG

Approval Date

2023-04-18

22544 / 3

Active Ingredient

GABAPENTIN

Application Number

22544

Product Number

3

Dosage Form

-

Strength

450MG

Approval Date

2023-04-18

Regulatory Status

RX

2023
18 Apr
RX Application: 22544

Drug Name

GRALISE

Product Number

4

Dosage Form

-

Strength

750MG

Approval Date

2023-04-18

22544 / 4

Active Ingredient

GABAPENTIN

Application Number

22544

Product Number

4

Dosage Form

-

Strength

750MG

Approval Date

2023-04-18

Regulatory Status

RX

2023
18 Apr
RX Application: 22544

Drug Name

GRALISE

Product Number

5

Dosage Form

-

Strength

900MG

Approval Date

2023-04-18

22544 / 5

Active Ingredient

GABAPENTIN

Application Number

22544

Product Number

5

Dosage Form

-

Strength

900MG

Approval Date

2023-04-18

Regulatory Status

RX

2023
09 May
RX Application: 215721

Drug Name

ZOLPIDEM TARTRATE

Product Number

1

Dosage Form

-

Strength

7.5MG

Approval Date

2023-05-09

215721 / 1

Active Ingredient

ZOLPIDEM TARTRATE

Application Number

215721

Product Number

1

Dosage Form

-

Strength

7.5MG

Approval Date

2023-05-09

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    7 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
7 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CITALOPRAM HYDROBROMIDE

Application Number

215428

Product Number

1

Active Ingredient

CITALOPRAM HYDROBROMIDE

Dosage Form

-

Strength

EQ 30MG BASE

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.